CureVac's shareholders approved all proposals relating to BioNTech SE's public exchange offer for all outstanding shares in ...
CureVac’s shareholders approved all proposals relating to BioNTech SE’s public exchange offer for all outstanding shares in CureVac (Offer) at the EGM with an approval rate of over 99.16% of the votes ...
I am glad that ACF has asked me to give a ten-minutes presentation on Arewa in the next 25 years. This is an indication that there is a new interest in trend analysis or futures studies within the ...
Calamos Phineus Long/Short Fund rose 1.29% in Q3 amidst AI bubble risk. Discover our strategy to navigate market shifts and ...
Shifting toward merit-based selection of public university board members can better protect academic freedom than politically appointed boards, which have increasingly exerted influence over state ...
The performance of skilled behaviors requires a balance between consistency and adaptability. Although the neural mechanisms that regulate this balance have been extensively studied at systems and ...
Dynein-2 is a motor protein essential for retrograde intraflagellar transport (IFT) on the A-tubule of ciliary doublet ...
PEN America has launched a digital portal to help writers in U.S. prisons connect with the literary world. The Incarcerated ...
This study presents a valuable tool named TSvelo, a computational framework for RNA velocity inference that models transcriptional regulation and gene-specific splicing. The evidence supporting the ...
Wellbeing research is growing worldwide, but without disability inclusion, it tells only part of the human story.
TÜBINGEN, DE AND BOSTON, MA / ACCESS Newswire / November 25, 2025 / CureVac N.V. (CureVac or the Company), a pioneering multinational biotech company developing a new class of transformative medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results